emedastine has been researched along with Kidney Failure in 1 studies
emedastine: structure given in first source
emedastine : 1-Methyl-1,4-diazepane in which the hydrogen attached to the nitrogen at position 4 is substituted by a 1-(2-ethoxyethyl)-1H-benzimidazol-2-yl group. A relatively selective histamine H1 antagonist, it is used as the difumatate salt for allergic rhinitis, urticaria, and pruritic skin disorders, and in eyedrops for the symptomatic relief of allergic conjuntivitis.
Kidney Failure: A severe irreversible decline in the ability of kidneys to remove wastes, concentrate URINE, and maintain ELECTROLYTE BALANCE; BLOOD PRESSURE; and CALCIUM metabolism.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Emedastine difumarate is a new H1 receptor antagonist with well defined pharmacokinetic and pharmacodynamic profiles in healthy volunteers." | 2.70 | Pharmacokinetics of emedastine difumarate, a new anti-histaminic agent in patients with renal impairment. ( Assandri, A; Eichler, HG; Herranz, U; Joukhadar, C; Klein, N; Lackner, E; Müller, M; Pernerstorfer, T; Schrolnberger, C, 2001) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Joukhadar, C | 1 |
| Herranz, U | 1 |
| Pernerstorfer, T | 1 |
| Assandri, A | 1 |
| Klein, N | 1 |
| Schrolnberger, C | 1 |
| Lackner, E | 1 |
| Eichler, HG | 1 |
| Müller, M | 1 |
1 trial available for emedastine and Kidney Failure
| Article | Year |
|---|---|
Pharmacokinetics of emedastine difumarate, a new anti-histaminic agent in patients with renal impairment.
Topics: Administration, Oral; Adult; Area Under Curve; Benzimidazoles; Female; Half-Life; Histamine H1 Antag | 2001 |